Printer Friendly

Dermatophytosis: Prevalence of Dermatophytes and Non-Dermatophyte Fungi from Patients Attending Arsho Advanced Medical Laboratory, Addis Ababa, Ethiopia.

1. Introduction

Diseases caused by fungi can be divided into three broad groups: superficial mycosis, subcutaneous mycosis, and systemic mycosis. Among superficial mycosis, dermatophytosis is the most common contagious infection. It is a fungal infection of the outermost layer of skin and its appendages such as hair and nails with scalp ringworm being the most common in children of school age and adult males, respectively [1-4]. Dermatophytosis is currently a disease of worldwide importance and a public health problem in many parts of the world particularly in developing countries [5, 6]. Although the disease hardly causes death, it is a common refractory infection deleteriously affecting the quality of life via social stigma and upsetting day-to-day activities [1]. Large population size, low socioeconomic status, inadequate health facilities, and exchanging of foot-wears, clothes, and barbershop materials among people in developing nation have been recognized as potential risk factors for the proliferation of the disease [1, 4].

Although species of Epidermophyton, Microsporum, and Trichophyton are the major cause of the mycosis [5, 7], an infection of skin and its appendage by non-dermatophyte molds and yeasts has been increasing [8-12]. Emergence of chronic diseases such as diabetes that resulted from an increase in the life expectancy of world population and suppression of host immune defense mechanisms by underlying diseases have made humans more susceptible not only to pathogenic fungi but also to all fungi that were once considered contaminants [13,14].

Dermatophytes and non-dermatophyte fungi implicated as a cause of dermatophytosis have been recorded all over the world, but with variation in distribution, incidence, epidemiology, clinical manifestations, and target hosts from one location to another. Differences in geographical location, health care, climatic factors, culture, and socioeconomic conditions are known to govern these discrepancies [15,16].

In Ethiopia, studies conducted on dermatophytosis are few and these studies are concentrated on tinea capitis caused by dermatophytes primarily in children of school age [17-20]. There are only two studies of fungal infection of nails, skin, and scalp by dermatophytes and/or non-dermatophyte fungi [21, 22]. Furthermore, most of these studies were conducted before 2006. To this end, investigating human dermatophytosis regardless of age, site, and the distribution of fungi implicated in causing superficial mycosis appears to be one of the priorities in health related studies in Ethiopia.

2. Materials and Methods

2.1. Study Population. This prospective study was conducted from May 2017 to April 2018 at Arsho Advanced Medical Laboratory, Addis Ababa, Ethiopia. The study involved 318 patients that are clinically diagnosed for superficial mycosis and referred to Arsho from different health institutions for laboratory diagnosis.

2.2. Specimen Collection. Prior to sample collection, written informed consent was completed and signed by adult study subjects. Consent form was completed and signed by parents and/or guardians for those study subjects under 16 years of age. Patient information was collected using standard format. Nail, skin, and scalp scrapings were collected aseptically using sterile blades and transferred into sterile plastic petri-dishes.

2.3. Laboratory Diagnosis. Non-fungal elements were digested by placing clinical samples onto 20% potassium hydroxide (KOH) in a microscopic slide for about 5 to 10 minutes. The KOH preparation then was examined for the presence of fungal elements under low (x10) and high (x40) power magnification objective lenses. A portion of each clinical specimen was also streaked onto Mycosel agar and Sabouraud's dextrose agar containing chloramphenicol and gentamycin but without cycloheximide (BBL, Decton, Dickinsn and Company, USA). All plates were incubated at room temperature (25[degrees]C) for a minimum of 4 weeks supervising them frequently for any fungal growth. Fungi were then identified by studying the macroscopic and microscopic characteristics of their culture. Texture, rate of growth, topography, and pigmentation of the front and the reverse side of the cultures were employed to characterize fungi macroscopically. Lactophenol cotton blue mount of each fungal isolate was used to characterize fungal isolates microscopically. Occasionally, urease test was used in the differentiation of T. tonsurans, T. violaceum, and T rubrum. Many mycological laboratory texts and manuals [23-25] were used as reference materials in process of identification. Yeasts were identified by means of conventional routine diagnostic methods [25] and chromogenic medium, CHROMagar Candida (bioMerieux, France) as per the instruction of the manufacturer.

Ethical Clearance. All ethical considerations and obligations were duly addressed. The study was carried out after the approval of the research and ethical committee of Arsho Advanced Medical Laboratory private limited company (AAMLRERC). Data collection was started after obtaining written informed consent from study subjects and assent form was completed and signed by parents and/or guardians. All the information obtained from the study subjects was coded to maintain confidentially.

3. Results

In this study, a total of 318 clinical samples were collected from suspected cases of dermatophytosis of which 122(38.4%) were from male and 196 (61.6%) from female patients. Tinea capitis was the predominant clinical manifestation consisting of 48.1% (153/318) of the cases. This was followed by tinea unguium and tinea corporis representing 18.9% (60/318) and 17.9% (57/318) of the cases, respectively (Table 1).

As shown in Table 2, out of 318 study subjects enrolled, fungi were detected and/or isolated in 213 (67.98%). One hundred thirty-one (41.2%) clinical samples were KOH positive while 154 (48.4%) clinical samples were culture positive. Mixed infections were observed in 3.1% (n = 10) of the culture positive cases. Fungi were neither detected nor showed visible fungal growth in 105 (33.3%).

As depicted in Table 3, clinical manifestation in relation to age was the highest in study subjects with age group of 1-14 (150) followed by age groups of 25-44 (98) and age groups of 15-24 (39), respectively. Out of 153 study subjects with tinea capitis, 73.2% (112/153) were < 14 years of age. Study subjects in age group of 25-44 were the second most affected, tinea corporis being the highest. Tinea pedis was recorded in study subjects with an age of > 25 years.

Among a total of 164 fungal isolates, dermatophytes were the most common isolates comprising 86 (52.4%) of the total isolates. T. violaceum was the dominant species involving 33 (38.4%) of the total dermatophyte isolates in which 29 (87.9%) of them were isolated from the scalp (Table 4). Seventy-eight isolates (47.6%) were non-dermatophyte fungi of which 69 (42.1%) were non-dermatophyte molds and the remaining 9 (5.5%) were yeasts. Aspergillus species (21), Scytalidium dimidiatum (13), and Cladosporium spp. (13) were the 1st and the 2nd common isolates of non-dermatophyte fungi (Table 5). Scytalidium dimidiatum was isolated from patients only with tinea corporis and tinea unguium.

4. Discussion

In the current study, the prevalence of dermatophytosis was high (66.98%). This is understandable, given that Ethiopia is a tropical country with wet humid climate, large population size, low socioeconomic status, and inadequate health facilities that are conducive for the proliferation of dermatophytosis. Strong correlations between dermatological infections and low socioeconomic conditions, geographical locations, climate, overcrowding, health care, and hygiene have been demonstrated by many researchers [26-28].

Fungi were not detected and isolated in 33.3% study subjects suspected of having superficial mycosis indicating that differentiation of dermatophytosis from other related superficial infections by clinical means only is not reliable. Coupling of clinical diagnosis with laboratory diagnosis appeared to be essential for better diagnosis as the cost and long duration of fungal therapy underline the significance of accurate diagnosis of the condition before starting therapy.

In our study, about seven different types of tinea were noted among which tinea capitis was the dominant clinical manifestation accounting for 48.1% of the total study subjects. According to Evans and Gentles [1], dermatophytosis affects both sexes, all ages, and all races, scalp ringworm being the predominant disease of children and tinea pedis being the predominant disease of adults, particularly adult males. Our result attested the work of Evans and his coworker [1] because, among study subjects with age ranging from 2 to 87 years, study subjects in the age range of 1-14 were the most affected with tinea capitis. Among 153 patients with tinea capits, 73.2% were in the age group of 1-14 years and tinea pedis was recorded in study subjects of >25 years of age. Differences in the amount of hormones before and after puberty [29] and insufficient production of fatty acids that have antifungal effect before puberty [30] are accountable for a difference in the prevalence of tinea capitis with age. Tinea capitis has been reported as the most frequent scalp infection affecting primary school children by previous studies conducted in Ethiopia [17-20]. These studies documented prevalence rates of tinea capitis in the range of 24.6-90%. In our study, tinea corporis, tinea unguium, and tinea pedis were less prevalent than tinea capitis. It has been reported that developing countries have high rates of tinea capitis, while developed ones have high rates of tinea pedis and onychomycosis [31]. High prevalence rates of tinea pedis and onychomycosis in developed countries have been related to increased urbanization of community showers, sports, and the use of occlusive footwear [16, 31, 32].

Out of 86 dermatophyte isolates in the present study, 69.8% were represented by T. violaceum, T. mentagrophytes, and M. audouinii, T. violaceum consisting of 38.4% of the total isolates and 89.7% isolated from patients with tinea capitis. Our finding was comparable with studies conducted in Ethiopia [17-20], many other African countries [33-35], and many Asian countries [36,37]. According to Ameen [32], T. violaceum is an endemic dermatophyte in East Africa and Asia. Furthermore, 95.3% of the dermatophytes in our study were anthropophilic in contrast to developed countries where the major dermatophytes are zoophilic [38]. Differences in the mode of transmission of dermatophytes in developing and developed countries may explain the variation. In developing countries, transmission of dermatophytes from man to man is indirect via fomites (materials which are likely to carry infection, such as clothes, utensils, barbershop materials, and furniture). In addition to this, overcrowded human setting in developing countries has been noted as the main risk factor [37], whereas rearing and close proximity to domestic pets have been reported as significant risk factors for the transmission of dermatophytes in developed countries [39].

Non-dermatophytic molds were isolated from 44.8% culture positive study subjects, nails and skins being the most affected regions of the body. Our result was in line with the findings of Greer [40]. According to Greer [40], out of 691 nail infections, non-dermatophyte molds were recovered from 53% of the cases. The significance of non-dermatophyte mold species in skin-related infections has been highlighted in other many published studies [41-45]. However, the extent to which non-dermatophyte molds actually cause dermatophytosis particularly when a dermatophyte is present concurrently is still a subject of debate. Therefore, further investigations demonstrating how this group of fungi causes infection are needed.

Among non-dermatophyte molds isolated in the present study, Aspergillus species stood first. Our result supported the findings of Aikaterini et al. [46] and Nouripour-Sisakht et al. [47].

In the current study, Scytalidium dimidiatum represents a significant percentage of the non-dermatophyte mold isolates. They were isolated from skin and nail scrapings predominantly of toenails. Scytalidium dimidiatum and Scytalidium hyalinum are responsible for nearly 40% human superficial infections in tropical and subtropical regions [48]. Cladosporium spp., Alternaria spp., Fusarium spp., and Scopulariopsis brevicaulis were other most commonly isolated non-dermatophyte molds recorded in our study. The significance of such non-dermatophyte molds in causing skin-related infections has been demonstrated in many other studies [49-51]. Similarly, Candida albicans has been isolated in 9 subjects with nail infection. Candida albicans as a major cause of tinea unguium has been documented in many studies [8-10,42, 44, 46, 47].

5. Conclusions

Failure to detect or isolate fungal pathogens in a large number of clinical samples revealed the limitation of clinical diagnosis in differentiating dermatophytosis from skin infection caused by other organisms noting that clinical diagnosis should be coupled with laboratory methods. Recovery of large number of non-dermatophyte fungi along with dermatophytes in our study showed that non-dermatophyte fungi are emerging as important causes of dermatophytosis, warranting the implementation of intensive epidemiological studies of dermatophytosis across the country.

Data Availability

The data used to support the findings of this work are available from the author upon request.

Conflicts of Interest

The work does not have financial and/or nonfinancial competing interest. The author declares that there are no conflicts of interest regarding the publication of this paper. The work is not funded by government or nongovernment organization.

https://doi.org/10.1155/2018/8164757

Acknowledgments

The author would like to acknowledge Arsho Advanced Medical Laboratory for the provision of laboratory supplies and space. The author is also indebted to the patients.

References

[1] E. G. V. Evans and J. C. Gentles, Essentials of Medical Mycology, Churchill Livingstone, 1st edition, 1985.

[2] M. Ogutu, Z. Ng'ang'a, M. Namasaka, and M. Wambura, "Superficial mycoses among psychiatric patients in Mathari Hospital, Nairobi, Kenya.," East African Medical Journal, vol. 87, no. 9, pp. 360-367, 2010.

[3] J. Del Boz-Gonzalez, "Tinea capitis: Trends in Spain," Actas Dermo-Sifiliograficas, vol. 103, no. 4, pp. 288-293, 2012.

[4] J. N. Moto, J. M. Maingi, and A. K. Nyamache, "Prevalence of Tinea capitis in school going children from Mathare, informal settlement in Nairobi, Kenya," BMC Research Notes, vol. 8, article 274, 2015.

[5] E. I. Nweze, "Dermatophytosis in Western Africa: a review," Pakistan Journal of Biological Sciences, vol. 13, no. 13, pp. 649-656, 2010.

[6] E. I. Nweze and I. Eke, "Dermatophytosis in northern Africa," Mycoses, vol. 59, no. 3, pp. 137-144, 2016.

[7] S. A. Adefemi, L. O. Odeigah, and K. M. Alabi, "Prevalence of dermatophytosis among primary school children in Oke-oyi community of Kwara state," Nigerian Journal of Clinical Practice, vol. 14, no. 1, pp. 23-28, 2011.

[8] H. Al Shekh, "Epidemiology of dermatophtes in the eastern province of Saudi Arabia," Research Journal of Microbiology, vol. 4, pp. 229-234, 2009.

[9] Z. Erbagci, A. Tuncel, Y. Zer, and I. Balci, "A prospective epidemiologic survey on the prevalence of onychomycosis and dermatophytosis in male boarding school residents," Mycopathologia, vol. 159, no. 3, pp. 347-352, 2005.

[10] S. Beena, M. V. Sreeja, P. R. Bhavana, and S. Sreenivasa Babu, "Onychomycosis, prevalence and its etiology in a tertiary care hospital, south India," International Journal of Health Sciences, vol. 3, pp. 81-85, 2013.

[11] P. Satpathi, A. Achar, D. Banerjee, A. Maiti, M. Sengupta, and A. Mohata, "Onychomycosis in Eastern India--study in a peripheral tertiary care centre," Journal of Pakistan Association of Dermatologists, vol. 23, no. 1, pp. 14-19, 2013.

[12] M. Ali Asadi, R. Dehghani, and M. R. Sharif, "Epidemiologic study of onychomycosis and tinea pedis in kashan, Iran," Jundishapur Journal of Microbiology, vol. 2, no. 2, pp. 61-64,

2009.

[13] K. Bramono and U. Budimulja, "Epidemiology of Onychomycosis in Indonesia: Data Obtained from Three Individual Studies," Nippon Ishinkin Gakkai Zasshi, vol. 46, no. 3, pp. 171-176, 2005.

[14] M. M. Batawi, H. Arnaot, S. Shoeib, M. Bosseila, M. El Fangary, and A. S. Helmy, "Prevalence of non-dermatophyte molds in patients with abnormal nails," Egyptian Journal of Dermatology and Venerology, vol. 2, pp. 11-15, 2006.

[15] J. R. Hay, "Fungal infections," in Oxford Textbook of Medicine, D. A. Warrell, T. M. Cox, J. D. Firth, and E. J. Benz Jr., Eds., Oxford University Press, Oxford, UK, 2003.

[16] B. Havlickova, V. A. Czaika, and M. Friedrich, "Epidemiological trends in skin mycoses worldwide," Mycoses, vol. 51, supplement 4, pp. 2-15, 2008.

[17] Y. Woldeamanuel, Y. Mengitsu, E. Chryssanthou, and B. Petrini, "Dermatophytosis in Tulugudu Island, Ethiopia," Medical Mycology, vol. 43, no. 1, pp. 79-82, 2005.

[18] Y. Woldeamanuel, R. Leekassa, E. Chryssanthou, Y. Menghistu, and B. Petrini, "Prevalence of tinea capitis in Ethiopian schoolchildren," Mycoses, vol. 48, no. 2, pp. 137-141, 2005.

[19] Y. Woldeamanuel, R. Leekassa, E. Chryssanthou, Y. Mengistu, and B. Petrini, "Clinico-mycological profile of dermatophytosis in a reference centre for leprosy and dermatological diseases in Addis Ababa," Mycopathologia, vol. 161, no. 3, pp. 167-172, 2006.

[20] M. Leiva-Salinas, I. Marin-Cabanas, I. Betlloch et al., "Tinea capitis in schoolchildren in a rural area in southern Ethiopia," International Journal of Dermatology, vol. 54, no. 7, pp. 800-805, 2015.

[21] G. Teklebirhan and A. Bitew, "Prevalence of Dermatophytic Infection and the Spectrum of Dermatophytes in Patients Attending a Tertiary Hospital in Addis Ababa, Ethiopia," International Journal of Microbiology, vol. 2015, 2015.

[22] G. Teklebirhan, "Profile of Dermatophyte and Non Dermatophyte Fungi in Patients Suspected of Dermatophytosis," American Journal of Life Sciences, vol. 3, no. 5, p. 352, 2015.

[23] D. H. Larone, Medically Important Fungi: A Guide to Identification, American Society for Microbiology (ASM) Press, Washington, DC, USA, 5th edition, 1995.

[24] D. Frey, R. J. Oldfield, and R. C. Bridger, "A color Atlas of Pathogenic FungI," in A color Atlas of Pathogenic Fungi, Wolfe Medical Publications Ltd, London, 2nd edition, 1981.

[25] M. Kern, Medical mycology, a self- instructional text, F. D Davis Company, Philadelphia, Pennsylvania, 2nd edition, 1985.

[26] V. K. Bhatia and P. C. Sharma, "Epidemiological studies on dermatophytosis in human patients in Himachal Pradesh, India," SpringerPlus, vol. 3, no. 1, pp. 1-7, 2014.

[27] P. N. Chowdhry and S. L. Gupta, "Diversity of fungi as human pathogen," in Recent Research in Science and Technology, vol. 5, pp. 17-20, 2013.

[28] S. Accorsi, G. A. Barnabas, P. Farese et al., "Skin disorders and disease profile of poverty: analysis of medical records in Tigray, northern Ethiopia, 2005-2007," Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 103, no. 5, pp. 469-475, 2009.

[29] JAA. Oliveira, JA. Barros, ACA. Cortez, and JSRL. Oliveira, "Superficial mycoses in the city of Manaus," in Superficial mycoses in the city of Manaus, pp. 238-243, An. Bras. Dermatol, 2006.

[30] G. David, C. B. Richard, M. Barer, and W. Irving, Medical Microbiology: a guide to microbial infections, pathogenesis, immunity, laboratory diagnosis and control, Churchill Livingstone, 2003.

[31] C. Seebacher, J.-P. Bouchara, and B. Mignon, "Updates on the epidemiology of dermatophyte infections," Mycopathologia, vol. 166, no. 5-6, pp. 335-352, 2008.

[32] M. Ameen, "Epidemiology of superficial fungal infections," Clinics in Dermatology, vol. 28, no. 2, pp. 197-201, 2010.

[33] M. Lange, R. Nowicki, W. Baranska-Rybak, and B. Bykowska, "Dermatophytosis in children and adolescents in Gdansk, Poland," Mycoses, vol. 47, no. 7, pp. 326-329, 2004.

[34] R. Caputo, K. De Boulle, J. Del Rosso, and R. Nowicki, "Prevalence of superficial fungal infections among sports-active individuals: Results from the Achilles survey, a review of the literature," Journal of the European Academy of Dermatology and Venereology, vol. 15, no. 4, pp. 312-316, 2001.

[35] A. M. Gargoom, M. B. Elyazachi, S. M. Al-Ani, and G. A. Duweb, "Tinea capitis in Benghazi, Libya," International Journal of Dermatology, vol. 39, no. 4, pp. 263-265, 2000.

[36] R. Kaur, B. Kashyap, and P. Bhalla, "Onychomycosis-epidemiology, diagnosis and management," Indian Journal of Medical Microbiology, vol. 26, no. 2, pp. 108-116, 2008.

[37] M. S. Ali-Shtayeh, A.-A. M. Salameh, S. I. Abu-Ghdeib, R. M. Jamous, and H. Khraim, "Prevalence of tinea capitis as well as of asymptomatic carriers in school children in Nablus area (Palestine)," Mycoses, vol. 45, no. 5-6, pp. 188-194, 2002.

[38] L. Trivino-Duran, J. M. Torres-Rodriguez, A. Martinez-Roig et al., "Prevalence of tinea capitis and tinea pedis in Barcelona Schoolchildren," The Pediatric Infectious Disease Journal, vol. 24, no. 2, pp. 137-141, 2005.

[39] J. G. Collee, A. G. Fraser, and J. G. Dugid, Practical Medical Microbiology, Churchill Livingstone Publishers, 14th edition, 1996.

[40] D. L. Greer, "Evolving role of non-dematophytes in onchomycosis," International Journal of Dermatology, vol. 34, pp. 521-524, 1995.

[41] H.-H. Tan, "Superficial fungal infections seen at the National Skin Centre, Singapore," Japanese Journal of Medical Mycology, vol. 46, no. 2, pp. 77-80, 2005.

[42] R. C. Summerbell, J. Kane, and S. Krajden, "Onychomycosis, tinea pedis and tinea manuum casused by non-dermatophytic filamentous fungi," Mycoses, vol. 32, no. 12, pp. 609-619, 1989.

[43] R. J. Hay and M. K. Moore, "Clinical features of superficial fungal infections caused by Hendersonula toruloidea and Scytalidium hyalinum," British Journal of Dermatology, vol. 110, no. 6, pp. 677-683, 1984.

[44] F. Baudraz-Rosselet, C. Ruffieux, M. Lurati, O. Bontems, and M. Monod, "Onychomycosis insensitive to systemic terbinafine and azole treatments reveals non-dermatophyte moulds as infectious agents," Dermatology, vol. 220, no. 2, pp. 164-168, 2010.

[45] S. Bakheshwai, N. El Khizzi, A. Al Rasheed, A. Al Ajlan, and S. Parvez, "Isolation of Opportunistic Fungi from Dermatophytic Samples," Asian Journal of Dermatology, vol. 3, no. 1, pp. 13-19, 2011.

[46] A. Tsentemeidou, T.-A. Vyzantiadis, A. Kyriakou, D. Sotiriadis, and A. Patsatsi, "Prevalence of onychomycosis among patients with nail psoriasis who are not receiving immunosuppressive agents: Results of a pilot study," Mycoses, vol. 60, no. 12, pp. 830-835, 2017.

[47] S. Nouripour-Sisakht, H. Mirhendi, M. R. Shidfar et al., "Aspergillus species as emerging causative agents of onychomycosis," Journal de Mycologie Medicale, vol. 25, no. 2, pp. 101-107, 2015.

[48] M. Machouart, P. Menir, R. Helenon, D. Quist, and N. Desbois, "Scytalidium and scytalidiosis: What's new in 2012?" Journal de Mycologie Medicale, vol. 23, no. 1, pp. 40-46, 2013.

[49] E. Mercier, I. R. Peters, F. Billen et al., "Potential role of Alternaria and Cladosporium species in canine lymphoplasmacytic rhinitis," Journal of Small Animal Practice, vol. 54, no. 4, pp. 179-183, 2013.

[50] A. Tosti, B. M. Piraccini, C. Stinchi, and S. Lorenzi, "Onychomycosis due to Scopulariopsis brevicaulis: Clinical features and response to systemic antifungals," British Journal of Dermatology, vol. 135, no. 5, pp. 799-802, 1996.

[51] M. R. V. Straten, M. M. Balkis, and M. A. Ghannoun, "The role of non-dermatophyte Molds in onchomycosis: Diagnosis and treatment," in Dermatologic Therapy, vol. 15, pp. 89-95, 2002.

Adane Bitew

Department of Medical Laboratory Sciences, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia

Correspondence should be addressed to Adane Bitew; bitewadane@gmail.com

Received 25 July 2018; Accepted 17 September 2018; Published 3 October 2018

Academic Editor: Craig G. Burkhart
Table 1: Frequency of clinical manifestation in relation to gender.

                                                    Sex
Clinical        Total number of samples
manifestation            n (%)            Male n (%)   Female n (%)

Tinea capitis         153 (48.1)          63 (19.8)     90 (28.3)
Tinea corporis         57 (179)            19 (6.0)     38 (11.9)
Tinea unguium          60 (18.9)           21 (6.6)     39 (12.3)
Tinea pedis            14 (4.4)            4 (1.3)       10 (3.1)
Tinea faci             14 (4.4)            5 (1.6)       9 (2.8)
Tinea groin             8 (2.5)            6 (1.9)        2(0.6)
Tinea manum            12 (3.8)            3 (0.9)        9(2.8)
Total                  318 (100)          122(38.4)     196(61.6)

Table 2: Correlation of direct microscopy and culture (n = 318).

Test procedure                   Number   Percentage

KOH positive                      131        41.2
Culture positive                  154        48.4
KOH negative culture positive      75        23.6
KOH positive culture negative      55        17.3
KOH and culture positive           62        19.5
KOH and culture negative          105        33.3

Table 3: Frequency of clinical manifestation in different age groups
(n=318).

                                               Age groups
Clinical
manifestation    Total sample   1-14   15-24   25-44   45-64   >65

Tinea capitis        153        112      9      24       7      1
Tinea corporis        57         15      8      28       4      2
Tinea unguium         60         13     18      22       6      1
Tinea pedis           14         --     --       9       4      1
Tinea faciei          14         7       1       5       1     --
Tinea manum           12         3       1       7       1     --
Tinea groin           8          --      2       3       2      1
Total                318        150     39      98      25      6

Table 4: Frequency and distribution of dermatophytes in relation to
clinical manifestation.

                                  Clinical presentation

Fungal isolates      Tinea capitis   Tinea corporis   Tinea unguium

T. violaceum              29               2                2
T. mentagrophytes          5               2                3
T. rubrum                  2               3               --
T. tonsurans              --               3                1
T. soudanense              1               1               --
T. verrucosum              2               --              --
T. schoenleinii            5               --              --
M. audouinii               8               2               --
Total                     47               10               5

                                Clinical presentation

Fungal isolates      Tinea pedis   Tinea faciei   Tinea groin

T. violaceum             --             --            --
T. mentagrophytes         4             --            --
T. rubrum                 2             1              1
T. tonsurans              1             --            --
T. soudanense             1             --             1
T. verrucosum            --             --            --
T. schoenleinii          --             --            --
M. audouinii             --             1             --
Total                     7             2              2

                     Clinical presentation

Fungal isolates      Tinea manuuin   Total

T. violaceum              --          33
T. mentagrophytes          1          15
T. rubrum                  1          10
T. tonsurans              --           5
T. soudanense             --           4
T. verrucosum             --           2
T. schoenleinii           --           5
M. audouinii               1          12
Total                      3          86

Table 5: Frequency and distribution of non-dermatophyte fungi in
relation to clinical manifestations.

                                 Clinical presentation

Fungal isolates               Tinea capitis   Tinea corporis

Scytalidium dimidiatum             --               2
Cladosporium spp                    5               5
Alternaria spp                      5               2
Fusarium spp                        1               2
Scopulariopsis brevicaulis         --               1
Phialophora                        --               3
Exophiala                           1               2
Exophiala werneckii                --               --
Fonsecaea spp                      --               1
Aspergillus niger                  --               2
Aspergellus fumigatus              --               3
A.teresus                          --               2
Candida albicans                    1               1
Total                              13               26

                                 Clinical presentation

Fungal isolates               Tinea unguium   Tinea pedis

Scytalidium dimidiatum             10             --
Cladosporium spp                    2             --
Alternaria spp                     --              1
Fusarium spp                        1              1
Scopulariopsis brevicaulis          4             --
Phialophora                        --             --
Exophiala                          --             --
Exophiala werneckii                --             --
Fonsecaea spp                      --             --
Aspergillus niger                  --             --
Aspergellus fumigatus               2             --
A.teresus                          --             --
Candida albicans                    7             --
Total                              26              2

                                          Clinical presentation

Fungal isolates               Tinea faciei   Tinea groin   Tinea manum

Scytalidium dimidiatum             1             --            --
Cladosporium spp                   --            --             1
Alternaria spp                     --            --            --
Fusarium spp                       1              1             1
Scopulariopsis brevicaulis         --            --             1
Phialophora                        --            --            --
Exophiala                          --            --            --
Exophiala werneckii                --            --             2
Fonsecaea spp                      --            --            --
Aspergillus niger                  1             --            --
Aspergellus fumigatus              1             --            --
A.teresus                          1             --            --
Candida albicans                   --            --            --
Total                              5              1             5

                              Clinical presentation

Fungal isolates                       Total

Scytalidium dimidiatum                 13
Cladosporium spp                       13
Alternaria spp                          8
Fusarium spp                            8
Scopulariopsis brevicaulis              6
Phialophora                             3
Exophiala                               3
Exophiala werneckii                     2
Fonsecaea spp                           1
Aspergillus niger                       3
Aspergellus fumigatus                   6
A.teresus                               3
Candida albicans                        9
Total                                  78
COPYRIGHT 2018 Hindawi Limited
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2018 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Research Article
Author:Bitew, Adane
Publication:Dermatology Research and Practice
Article Type:Report
Geographic Code:6ETHI
Date:Jan 1, 2018
Words:4235
Previous Article:Experience with Treating Lentigo Maligna with Definitive Radiotherapy.
Next Article:Investigation of Interleukin-27 in the Sera of Nonmelanoma Skin Cancer Patients.
Topics:

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |